← peptides typeshit

David W. Higgins backs NCPE picking Wegovy over Mounjaro on cost grounds

Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.

See it on X

Recap by typeshit. Post by David W. Higgins on X.